Agilent Technologies Inc (A)
139.64
+1.86
(+1.35%)
USD |
NYSE |
Nov 07, 16:00
139.64
0.00 (0.00%)
After-Hours: 18:39
Agilent Technologies Revenue (Annual): 6.833B for Oct. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
October 31, 2023 | 6.833B |
October 31, 2022 | 6.848B |
October 31, 2021 | 6.319B |
October 31, 2020 | 5.339B |
October 31, 2019 | 5.163B |
October 31, 2018 | 4.914B |
October 31, 2017 | 4.472B |
October 31, 2016 | 4.202B |
October 31, 2015 | 4.038B |
October 31, 2014 | 4.048B |
October 31, 2013 | 3.894B |
October 31, 2012 | 6.858B |
October 31, 2011 | 6.615B |
Date | Value |
---|---|
October 31, 2010 | 5.444B |
October 31, 2009 | 4.481B |
October 31, 2008 | 5.774B |
October 31, 2007 | 5.42B |
October 31, 2006 | 4.973B |
October 31, 2005 | 4.685B |
October 31, 2004 | 4.556B |
October 31, 2003 | 4.468B |
October 31, 2002 | 6.01B |
October 31, 2001 | 8.396B |
October 31, 2000 | 9.361B |
October 31, 1999 | 6.83B |
October 31, 1998 | 7.952B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.339B
Minimum
2020
6.848B
Maximum
2022
6.335B
Average
6.576B
Median
Revenue (Annual) Benchmarks
Bio-Rad Laboratories Inc | 2.671B |
Bruker Corp | 2.964B |
Azenta Inc | 665.07M |
Harvard Bioscience Inc | 112.25M |
Bionano Genomics Inc | 36.12M |